KOP insider files Form 144 to sell 2,448 shares via Fidelity on NYSE
Rhea-AI Filing Summary
Koppers Holdings, Inc. (KOP) has filed a Form 144 to notify a proposed sale of 2,448 shares of common stock through Fidelity Brokerage Services on the NYSE with an aggregate market value of $74,620.86. The shares were acquired on 03/04/2022 via restricted stock vesting and were paid as compensation. The filer reports no securities sold in the past three months and provides the standard representation that they do not possess undisclosed material adverse information about the issuer.
Positive
- Full transaction details disclosed including broker, exchange, share count, and aggregate market value
- Securities acquired via restricted stock vesting and paid as compensation, clarifying the origin of the shares
Negative
- Insider proposes to sell common shares, representing a liquidity event for an insider
- Filing does not identify the specific selling person by name in the provided content
Insights
TL;DR: Small insider sale notification; transaction details disclosed precisely, unlikely to be material for valuation.
The Form 144 reports a proposed sale of 2,448 common shares valued at $74,620.86 executed through Fidelity on the NYSE. The shares originate from restricted stock vesting and were received as compensation on 03/04/2022. For a company of material scale, this size of sale typically has limited market impact but is relevant as an insider liquidity event. The filing confirms no sales in the prior three months, supporting that this is an isolated transaction rather than a pattern of disposals.
TL;DR: The disclosure meets Rule 144 requirements and documents compensation-related vesting; governance signal is neutral.
The notice provides required broker, share count, acquisition method, and payment nature information. That the shares resulted from restricted stock vesting indicates the disposition is tied to compensation rather than an immediate performance-driven sale. The statement attesting to absence of undisclosed material adverse information is standard. This filing should be processed as routine insider disclosure under governance best practices.